Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-12.98%
202467.00%
202323.74%
202292.22%
202134.06%
202030.12%
2019234.65%
2018-87.04%
201723.50%
20160.29%